Entera Bio Ltd. filed a Form D with the Securities and Exchange Commission on 2026-08-12.
Entera Bio Ltd. filed a Form D notice of an exempt securities offering with the SEC on August 12, 2026. Entera Bio Ltd. trades on Nasdaq as ENTX. The filing reports $275M sold. Its industry group is Biotechnology. It names Miranda Toledano (Chief Executive Officer), Haya Taitel (Director), Yonatan Malca (Director) (SEC Form D, August 12, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Entera Bio Ltd.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Entera Bio Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Entera Bio Ltd.
Free to see. No signup.
More on the people and the money behind Entera Bio Ltd., from the filings we hold.
Biotechnology raises by companies based in Israel, filed within 90 days of this one, largest first.
Get an email when Entera Bio Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Entera Bio Ltd. raises, hires or launches. No email unless you switch it on.
Watch Entera Bio Ltd. →Get the full cited report on Entera Bio Ltd.
What the filing shows about Entera Bio Ltd.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Entera Bio Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Entera Bio Ltd.'s address as Kiryat Hadassah - Minray Building, Fifth Floor, Jerusalem, L3 9112002.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Entera Bio Ltd. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Entera Bio Ltd. is a registered filer with the SEC (CIK 1638097) and has filed since 2024-01-02. 2 filings are on record, the latest on 2026-08-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Entera Bio Ltd.'s Form D of 2026-08-12 names Miranda Toledano, Haya Taitel, Yonatan Malca and 4 more as its officers, directors or promoters.
Its new offerings report $281.61M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $275M, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer, Director.
Miranda Toledano is named as Chief Executive Officer on the Form D that Entera Bio Ltd. filed with the SEC on 12 August 2026, one of 7 people that filing names.
Haya Taitel is named as Director on the Form D that Entera Bio Ltd. filed with the SEC on 12 August 2026, one of 7 people that filing names.
Yonatan Malca is named as Director on the Form D that Entera Bio Ltd. filed with the SEC on 12 August 2026, one of 7 people that filing names.
On the filing as: Executive Officer.
Dana Yaacov-Garbeli is named as Chief Financial Officer on the Form D that Entera Bio Ltd. filed with the SEC on 12 August 2026, one of 7 people that filing names.
On the filing as: Director.
Geno Germano is named as Chairman of the Board on the Form D that Entera Bio Ltd. filed with the SEC on 12 August 2026, one of 7 people that filing names.
Sean Ellis is named as Director on the Form D that Entera Bio Ltd. filed with the SEC on 12 August 2026, one of 7 people that filing names.
Steven Rubin is named as Director on the Form D that Entera Bio Ltd. filed with the SEC on 12 August 2026, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2026-08-12 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Entera Bio Ltd.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Entera Bio Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Entera Bio Ltd. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Entera Bio Ltd.You get an alert in MentionFox the next time this company shows up.
If you're behind Entera Bio Ltd.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Entera Bio Ltd.. With no account yet, you sign up free and land on the result.
On these lists: Outside the US raises, week of 2026-08-10 · Biotech raises, week of 2026-08-10
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/entera-bio-ltd-form-d-26000001